CAS: 19690-23-4; 6-Iodo-9H-Purin-2-Amine

该化合物是一种纯衍生物,其特点是在2点有一个氨基组,在纯度环的6点有一个碘原子.该化合物一般是白色至白晶状固体,可溶于极溶剂,如水和酒精,有利于其在各种生物化学应用中使用.氨基氨基化合物的存在有助于其基本性,而碘原子可加强其再活性和替代反应的潜力.2-Amino-6-iodopurine经常用于核酸研究,并用作核核素类素合成的建筑块,这可能会对抗病毒和抗癌疗法产生影响.其分子结构允许它参与氢结合,使其与分子相互作用和酶机制的研究有关.与许多化学物质一样,适当的处理和安全防范措施由于其潜在的生物活动和再活性而必不可少.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号10310-21-1 2-氨基-6-氯嘌呤 | CAS号7440-44-0 活性炭 | CAS号132194-23-1 (2S)-5α-(2-Amin...

合成工艺路线路线简述

  • 合成目标产物 2-Amino-6-Iodopurine 主要起始原料 6-Chloroguanine
  • (文献来源)合成步骤主要原料 6-Chloroguanine
2-氨基-6-氯嘌呤置于氢碘酸体系中,用 水 用作溶剂,以77 %的收率获得2-氨基-6-碘嘌呤
参考文献:Fraglites-最小的,卤代的碎片,显示药效基团双峰.一种有效的药物可及性评估和命中方法.
标题:Fraglites-最小的,卤代的碎片,显示药效基团双峰.一种有效的药物可及性评估和命中方法.
摘要:鉴定蛋白质上的配体结合位点是基于靶标的药物发现中的关键步骤.当前的解决方法要求对铅样或片段分子的大型文库进行资源密集型筛选.在这里,我们描述了一种高效而有效的实验方法,用于使用一组表达成对的氢键基序的卤化化合物(称为fraglite)来绘制相互作用位点.Fraglite利用卤素取代基的反常散射,识别出类似于药物的生产性相互作用,通过x射线晶体学可以灵敏而明确地识别出这种相互作用.蛋白质相互作用表面的这种作图提供了可药用性的评估,并且可以为结合相互作用基序的命中分子的从头设计确定有效的起点.通过对细胞周期蛋白依赖性激酶2作图来说明该方法,该激酶成功鉴定了正构和变构位点.命中被迅速完善,以开发有效的铅样分子.因此,该方法提供了一种识别配体位点,评估易加工性和发现新线索的新方法.
Doi:10.1021/acs.Jmedchem.9B00304

专利信息


专利号:US-7189849-B2
优先权日:1997-02-10
标 题:Synthesis of acyclic nucleoside derivatives
发明人:LEANNA M ROBERT; RASMUSSEN MICHAEL; HANNICK STEVEN M; TIEN JIEN-HEH J; LUKIN KIRILL A; TIAN ZHENPING; CHANG SOU-JEN; CURTY CYNTHIA B; NARAYANAN BIKSHANDARKOIL A; BELLETTINI JOHN; SHELAT BHADRA; SPITZ TIFFANY
权利人:MEDIVIR AB
摘要:Novel processes towards the synthesis of the antiviral valomaciclovir stearate in which an esterified guanine acetal is reduced to the corresponding alcohol, reacted with an activated amino acid and N-deprotected. The esterified guanine acetal is prepared from a 9-guanine derivative bearing an acyclic hydroxymethylbutylacetal. The processes are amendable to one-pot reactions.

专利号:US-6316228-B1
优先权日:1996-10-21
标题 :Efficient synthesis of nucleosides
发明人:NAIR VASU; PAL SURESH
权利人:UNIV IOWA RES FOUND
摘要:Methods and compositions, including cell cultures, for producing nucleosides are provided which comprise contacting a nucleoside precursor and a sugar moiety donor with a cell containing a nucleoside phosphorylase. The nucleoside precursor can be a purine or pyrimidine base and the sugar moiety donor can comprise a ribose, a deoxyribose, including 2-deoxyribose, or other sugar of choice. The methods and composition can be used to make thymidine from thymine and 2-deoxyinosine or 2′-deoxyadenosine. Other nucleosides, including those having anticancer and/or antiviral properties, also can be obtained according to the invention.

专利号:US-5440037-A
优先权日:1991-11-22
标题 :Method for production of 2-amino-6-halogenopurine derivatives
发明人:IGI MASAMI; HAYASHI TAKETO
权利人:SUMIKA FINE CHEMICALS CO LTD
摘要:The present invention is directed to a method for production of a 2-amino-6-halogenopurine, a novel synthesis intermediate therefor and a method for production of said synthesis intermediate. The desired 2-amino-6-halogenopurine is an intermediate for the production of the compounds useful as antiviral agents, and by using the compound of the present invention as a starting material, the 2-amino-6-halogenopurine can be produced in high yield.

专利号:US-7411065-B2
优先权日:2002-04-26
标 题 :PNA monomer and precursor
发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; CHOI HOON; JEON JAE HOON; AHN SANG YOUL; LEE SUNG HEE; YOON WON JUN
权利人:PANAGENE INC
摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oglimers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

专利号:US-2004024214-A1
优先权日:1997-02-10
标 题 :Synthesis of acyclic nucleoside derivatives

专利号:US-2004248910-A1
优先权日:1997-02-10
标题:Synthesis of acyclic nucleoside derivatives
上药康丽(常州)药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.kanglipharm.com
电话: 0519-88555711 88556800👤
📞上药康丽(常州)药业有限公司 ⚠️参考联系方式

销售电话:0519-88555711 88556800
邮箱:konypharm@jsmail.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题: Pna Monomer And Precursor Monomere Et Precurseur Pna
摘要:This Application Relates To Monomers Of The General Formula (I) For The Preparation Pna (Peptide Nucleic Acid) Oligomers And Provides Method For The Synthesis Of Both Predefined Sequence Pna Oligomers And Random Sequence Pna Oligomers: (I) Wherein E Is Nitrogen Or C-R'; J Is Sulfur Or Oxygen; R', Rl, R2, R3, R4 Is Independently H, Halogen, Alkyl, Nitro, Nitrile, Alkoxy, Halogenated Alkyl, Halogenated Alkoxy, Phenyl Or Halogenated Phenyl, Rs Is H Or Protected Or Unprotected Side Chain Of Natural Or Unnatural A-Amino Acid; And B Is A Natural Or Unnatural Nucleobase, Wherein When Said Nucleobase Has An Exocyclic Amino Function, Said Function Is Protected By Protecting Group Which Is Labile To Acids But Stable To Weak To Medium Bases In The Presence Of Thiol.

合成参考文献


摘要:Seela, F.; Ramzaeva, N.; Rosemeyer, H., Science of Synthesis, (2004) 16, 1021.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知